CLINICAL RESEARCH

临床研究

• 批准号: 6563764
• 负责人: HYMAN MUSS
• 金额: $ 7.89万
• 依托单位: UNIVERSITY OF VERMONT & ST AGRIC COLLEGE
• 依托单位国家: 美国
• 财政年份: 2001
• 资助国家: 美国
• 起止时间: 2001-12-01 至 2002-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6563764
• 关键词: breast neoplasms; clinical research; cognitive behavior therapy; coping; female; female reproductive system neoplasm; human subject; human therapy evaluation; neoplasm /cancer chemotherapy; neoplasm /cancer diagnosis; prognosis; psychological aspect of cancer; raloxifene; social support network; tamoxifen; urinary tract neoplasms; women's health

The Clinical Research Program is dedicated to high quality clinical research directed at all aspects of cancer diagnosis, prognosis, treatment, and survivorship. The program lists 29 members with diverse expertise in all aspects of cancer care and research. Program progress and development sin the last 3 years are highlighted by recruitment of faculty with new research interested, targeted efforts to develop translational research activities in selected areas, and growth and enhancement of in- house and cooperative group clinical trials and outreach program./ A major focus of this program is on breast cancer, with recent growth of research activities in gynecologic and genitourinary cancer. Specific research studies in the program range from well-established behavioral research related to cancer diagnosis, to clinical interventions including in- house and cooperative group therapeutic trials, to development of a national surgical trial, to first-in-human studies including innovative developmental therapeutic research, to educational studies and programs related to physician, nursing and patient education. The Program Leader is Hyman Muss, M.D., Professor of Medicine and Associate Director for Clinical Research.

临床研究计划致力于针对癌症诊断，预后，治疗和生存的各个方面的高质量临床研究。该计划列出了29名在癌症护理和研究各个方面具有不同专业知识的成员。计划的进步和发展罪是通过招募教师的招募，他们对新的研究感兴趣，有针对性的努力在选定领域开发转化研究活动，以及在内部和合作团体临床试验和外展计划中的成长和增强。该计划的特定研究范围从与癌症诊断有关的良好行为研究到包括内部和合作组织治疗试验在内的临床干预措施，再到国家手术试验的发展，再到包括创新的发展治疗研究，以及与医师，护士，护理和患者教育有关的创新性发展治疗研究，以及与教育研究以及与教育研究和计划有关。该计划负责人是医学教授兼临床研究副总监海曼·穆斯（Hyman Muss）。